Free Trial
NASDAQ:SCPS

Scopus BioPharma (SCPS) Stock Price, News & Analysis

Scopus BioPharma logo
$0.0003 0.00 (0.00%)
As of 03/28/2025

About Scopus BioPharma Stock (NASDAQ:SCPS)

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.0001
$0.01
Volume
N/A
Average Volume
2,532 shs
Market Capitalization
$12,625.20
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs. It offers Duet Platform, which consists of signal transducer and activator of transcription 3 (STAT3), a master immune checkpoint inhibitor and toll-like receptor 9 (TLR9), as well as includes CpG-STAT3ASO (DUET-02), CpG-STAT3siRNA (DUET-01), and CpG-STAT3decoy (DUET-03); and that develops a suite of bifunctional oligonucleotides that activate antigen-presenting cells (APCs) in the tumor microenvironment that alleviates tumor immunosuppression to jump-start T cell-mediated immune responses. The company is also developing DUET-01, as a monotherapy targeting B-cell non-Hodgkin lymphoma; DUET-02 that provides systemic delivery for treatment of solid tumors comprising prostate or kidney cancers; and DUET-03, which targets the actual STAT3 transcription factor protein. Scopus BioPharma Inc. has licensing agreements with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.

Remove Ads
Receive SCPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scopus BioPharma and its competitors with MarketBeat's FREE daily newsletter.

SCPS Stock News Headlines

Scopus Biopharma Inc Price / Book
Elon Musk just flipped the script on AI
Elon Musk’s Secret AI Project Could Spark the Next Stock Explosion Elon Musk just blindsided Nvidia, Microsoft, and Google with a secret AI project set to reshape the industry. Few investors are aware, but those who are could seize a once-in-a-lifetime profit opportunity—without buying Tesla or OpenAI. I've identified a hidden "backdoor" stock positioned to soar once Musk’s AI vision becomes public. But this under-the-radar opportunity won’t last long.
Scopus Biopharma Inc (SCPS)
ArriVent BioPharma Inc AVBP
Scopus BioPharma Inc. (SCPS)
See More Headlines

SCPS Stock Analysis - Frequently Asked Questions

Scopus BioPharma's stock was trading at $0.0003 at the start of the year. Since then, SCPS shares have increased by 0.0% and is now trading at $0.0003.
View the best growth stocks for 2025 here
.

Shares of SCPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Scopus BioPharma investors own include Plug Power (PLUG), Canoo (GOEV), NIO (NIO), SNDL (SNDL), Tesla (TSLA), Moderna (MRNA) and VYNE Therapeutics (VYNE).

Company Calendar

Today
3/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SCPS
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
39,938,000
Market Cap
$12,625.20
Optionable
Not Optionable
Beta
-0.22
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:SCPS) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners